We report herein a case of adult T-cell leukemia/lymphoma (ATLL), with the development of HBV reactivation-related hepatitis during chemotherapy for ATLL and successful treatment with a combination of entecavir and short-term administration of interferon (IFN)-β 3 MIU twice per day. The gene discussed is PPIB; the disease is hepatitis A virus infection.